2015
Lancet JE, Cyr PL , Sacks NC , Chiarella MT, Louie AC, Cortes JE. CPX-351 enables administration of consolidation treatment in the outpatient setting and increases the time spent out of the hospital after completion of AML treatment compared with 7+3. American Society of Hematology Annual Meeting, San Diego CA, 2015.
Publication: Abstracts and Presentations
Proctor D, Suh M , Thompson C, Hixon, G. Inhalation cancer risk assessment of titanium dioxide. Presented at Society of Toxicology 54th Annual Meeting, San Diego, CA, March 2015.
View Abstract
Publication: Abstracts and Presentations
2014
Proctor DM, Suh M , Campleman SL, Thompson CM. 2014. Assessment of the mode of action for hexavalent chromium-induced lung cancer following inhalation exposures. Toxicology 325(Nov):160-179; doi: 10.1016/j.tox.2014.08.009 . PMID: 25174529.
View Abstract
Publication: Manuscripts
Erichsen R, Kelsh MA , Oliner KS, Nielsen KB, Frøslev T, Lænkholm AV, et al. Prognostic impact of tumor MET expression among patients with stage IV gastric cancer: A Danish cohort study. Presented at International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Taipei, Taiwan, October 28–30, 2014.
Publication: Abstracts and Presentations
Thompson CM, Kirman CR, Proctor DM, Haws LC, Suh M , Hays S, Hixon JG, Harris MA. 2014. A chronic oral reference dose for hexavalent chromium-induced intestinal cancer. J Appl Toxicol 34(5):525-536. doi: 10.1002/jat.2907 . PMID: 23943231.
View Abstract
Publication: Manuscripts
Jensen IS , Halbert RJ, Thompson SF, Hennessy D, Pacconi S, McSweeney PA. Increased use of plerixafor in patients with multiple myeloma and non-Hodgkin’s lymphoma in the United States: A budgetary impact analysis. Abstract C14 , Academy of Managed Care Pharmacy 26th Annual Meeting & Expo, 2014.
View Abstract
Publication: Abstracts and Presentations
2013
Chia VM, O’Malley CD, Danese MD, Lindquist KJ, Gleeson ML, Kelsh MA , et al. 2013. Prevalence and incidence of comorbidities in elderly women with ovarian cancer. Gynecol Oncol 129(2):346–352; doi: 10.1016/j.ygyno.2013.02.014 . PMID: 23422502.
View Abstract
Publication: Manuscripts
Lowe KA, Chia VM, Taylor A, O’Malley C, Kelsh M , Mohamed M, et al. 2013. An international assessment of ovarian cancer incidence and mortality. Gynecol Oncol 130(1):107–114; doi: 10.1016/j.ygyno.2013.03.026 . PMID: 23558050.
View Abstract
Publication: Manuscripts
Fryzek J, Pastula S , Jiang X , Garabrant DH. 2013. Childhood cancer incidence in Pennsylvania counties in relation to living in counties with hydraulic fracturing sites. J Occup Environ Med 55(7):796–801; doi: 10.1097/JOM.0b013e318289ee02 . PMID: 23836020.
View Abstract
Publication: Manuscripts
Proctor DM, Suh M, Thompson CM, Harris MA. 2013. Mode of action evaluation for hexavalent chromium-induced lung cancer. Presented at Society of Toxicology 52nd Annual Meeting, March 10-14, San Antonio, TX.
View Abstract
A Division of